MedCity News April 23, 2021
Frank Vinluan

The five life sciences IPOs this week continues the steady march companies are making to the public markets this year. This week’s activity follows a first quarter that Renaissance Capital calculates was the busiest for newly public companies since 2000. Healthcare IPOs continued to dominate the stock offerings.

The strong IPO market continued its march forward, with five life sciences companies joining the public markets this week. The biggest IPO of the week belongs to a biotech company that isn’t working in healthcare—at least not yet. This week’s IPO tally also included commercial-stage medical device makers looking to ramp up their sales and marketing plans.

The second quarter IPO activity so far follows the busiest quarter for newly public companies...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Investments, Medical Devices, Pharma / Biotech, Trends
Pelago Defies Digital Health Funding Drought, Raises $58M
Digital health venture capital deals stagnate
Boundless Bio’s ‘BOLD’ IPO Reels In $100M for a New Kind of Cancer Drug
Is AI’s next big leap understanding emotion? $50M for Hume says yes
Oxford University Venture Capital Network: Insights into Digital Health Report

Share This Article